IBBQ:NSD-Invesco Nasdaq Biotechnology ETF (USD)

ETF | Others |

Last Closing

USD 20.36

Change

-0.07 (-0.34)%

Market Cap

USD 0.04B

Volume

0.04M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-22 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
IBIT iShares Bitcoin Trust

-1.40 (-2.21%)

USD 65.59B
QQQM Invesco NASDAQ 100 ETF

-2.01 (-0.95%)

USD 39.18B
JEPQ JPMorgan Nasdaq Equity Premium..

-0.19 (-0.36%)

USD 22.49B
ACWI iShares MSCI ACWI ETF

-0.38 (-0.31%)

USD 19.99B
CGABL The Carlyle Group Inc. 4.625% ..

-0.07 (-0.42%)

USD 16.14B
SNDK Sandisk Corp

-0.56 (-1.48%)

USD 5.99B
TBIL Rbb Fund Inc - Us Treasury 3 M..

+0.03 (+0.06%)

USD 5.43B
TSLL Direxion Shares ETF Trust - Di..

-0.14 (-0.96%)

USD 4.44B
NVDL GraniteShares 1.5x Long NVDA D..

-1.19 (-2.34%)

USD 3.52B
USCL iShares Climate Conscious & Tr..

-0.38 (-0.55%)

USD 2.21B

ETFs Containing IBBQ

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -5.39% 23% F 50% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.39% 23% F 49% F
Trailing 12 Months  
Capital Gain -8.08% 22% F 45% F
Dividend Return 0.63% 22% F 14% F
Total Return -7.45% 21% F 44% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 0.35% 47% F 45% F
Dividend Return 0.71% 40% F 41% F
Total Return 0.36% 26% F 11% F
Risk Return Profile  
Volatility (Standard Deviation) 11.70% 49% F 87% B+
Risk Adjusted Return 6.11% 35% F 43% F
Market Capitalization 0.04B 51% F 25% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.